Keyphrases
Vaccine Design
100%
T Cells
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Immunodetection
100%
Peripheral Blood Mononuclear Cells
40%
HIV-1 Gag
40%
HIV Vaccine
40%
CD8+ T Cells
20%
Infected Individual
20%
Developing Countries
20%
ELISPOT
20%
Interferon Production
20%
Cryopreserved
20%
Peptide Pools
20%
Amino Acid Substitution
20%
Matrix Algorithm
20%
CD8+ T Lymphocytes
20%
Initial Matrix
20%
Enzyme-linked Immunospot Assay
20%
Broad Response
20%
Immunodominant Region
20%
HIV-1 Subtype B
20%
Matrix Format
20%
Candidate Evaluation
20%
Assay Matrix
20%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
100%
T Cell
100%
Cladistics
100%
Enzyme
28%
Peripheral Blood Mononuclear Cell
28%
CD8
28%
Interferon Production
14%
Amino Acid Substitution
14%
Human Immunodeficiency Virus Type 1 Subtype A
14%
Human Immunodeficiency Virus Type 1 Subtype B
14%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
HIV Type 1
100%
T Cell
100%
Cladistics
100%
Peripheral Blood Mononuclear Cell
28%
Cytotoxic T-Cell
14%
Enzyme-Linked Immunospot Assay
14%
Interferon Production
14%
Amino Acid Substitution
14%
CD8+ T Lymphocyte
14%
Human Immunodeficiency Virus Type 1 Subtype B
14%
Human Immunodeficiency Virus Type 1 Subtype A
14%